Cargando…
Recent advances in primary resistance mechanisms against immune checkpoint inhibitors
The resistance of immune checkpoint inhibitors (ICIs) has become an obstacle to further improve the survival of patients with advanced cancer. This review provides an overview of recent advances in primary resistance mechanisms of ICIs. RECENT FINDINGS: With the improvement of study approach, new ch...
Autores principales: | Li, Yi-Ze, Zhang, Hong-Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654244/ https://www.ncbi.nlm.nih.gov/pubmed/34669646 http://dx.doi.org/10.1097/CCO.0000000000000802 |
Ejemplares similares
-
Tyrosine kinase inhibitors as induction therapy in nonsmall-cell lung cancer
por: Gong, Juejun, et al.
Publicado: (2021) -
HIGH INCIDENCE OF SPONTANEOUS PNEUMOTHORAX IN CRITICALLY ILL PATIENTS WITH SARS-COV-2
por: Reddy, Renuka, et al.
Publicado: (2020) -
SPONTANEOUS PNEUMOMEDIASTINUM IN PATIENTS WITH SARS-COV-2 VIRUS (COVID-19)
por: Ghani, Marium, et al.
Publicado: (2020) -
INCIDENTAL FINDING OF A PERICARDIAL CYST IN A HOSPITALIZED PATIENT WITH COVID-19 PNEUMONIA
por: AGLADZE, MARIAM, et al.
Publicado: (2021) -
A REPORT OF SECONDARY PNEUMOMEDIASTINUM DUE TO CPAP NONINVASIVE VENTILATION IN COVID-19 TREATMENT
por: THOMAS, PRAVIN, et al.
Publicado: (2021)